Peer-reviewed Publications 2025

  1. Viremia Does Not Independently Predict Cardiovascular Disease in People With HIV: A RESPOND Cohort Study Elvstam O, Ryom L, Neesgaard B, Tau L, Günthard HF, Zangerle R, Vehreschild JJ, Wit F, Sönnerborg A, Kovari H, Abutidze A, Petoumenos K, Jaschinski N, Hosein S, Bogner J, Grabmeier-Pfistershammer K, Garges H, Rooney J, Young L, Law M, Kirk O; RESPOND Study Group.
    Open Forum Infect Dis. 2025 Jan;12(2):ofaf016.  Abstract

  2. A simple tool to evaluate the effectiveness of HIV care for settings with gaps in data availability (ESTIHIV) Raben D, Jakobsen ML, Trajanovska J, Kowalska J, Vassilenko A, Dragas S, Harxhi A, Dragovic G, Jaschinski NJ, Neesgaard B, Hjorth-Larsen K, Garges H, Gallant J, Lundgren JD, Philips A, Cambiano V, Yazdanpanah Y, Mocroft A.
    PLoS One. 2025 Jan;20(1):e0316794.  Abstract

  3. Risk of cancer in people with HIV experiencing varying degrees of immune recovery with sustained virological suppression on antiretroviral treatment for more than 2 years: an international, multicentre, observational cohort. Han WM, Ryom L, Sabin CA, Greenberg L, Cavassini M, Egle A, Duvivier C, Wit F, Mussini C, d'Arminio Monforte A, Castagna A, Miro JM, van der Valk M, Bonnet F, Pradier C, Skocic M, Matulionyte R, Stöckle M, Jaschinski N, Timiryasova A, Tallada J, Rogatto FP, Vannappagari V, Young LA, Lundgren JD, Petoumenos K, Hoy JF.
    Clin Infect Dis. 2025 May:ciaf248. Epub ahead of print.   Abstract

  4. Incident tuberculosis in people with HIV across Europe from 2012 to 2022: incidence rates, risk factors and regional differences in a multicentre cohort study.  Kraef C, Roen A, Podlekareva D, Bakowska E, Nemeth J, Knappik M, Payen MC, Wit F, Mussini C, d'Arminio Monforte A, Castagna A, Chkhartishvili N, Neesgaard B, Jaschinski N, Anne AV, Borodulina E, Ballif M, Wallner E, Israelski D, Garges H, Mocroft A, Kirk O; RESPOND Study Group.
    Eur Respir J. 2025 Jun;65(6):2401904.   Abstract

  5. Mortality using raltegravir versus other integrase strand-transfer inhibitors in people with HIV in Europe and Australia: a prospective multicentre study Tusch E, Ryom L, Hoffmann C, Degen O, Zangerle R, Günthard HF, Wit F, Mussini C, Castagna A, Martin C, Giacomelli A, Vehreschild JJ, Begovac J, Vannappagari V, Rooney J, Mendes SDS, Tallada J, Kowalska J, Wallner E, Kusejko K, Naschinski N, Lundgren J, Peters L, Reekie J
    eClinicalMedicine 2025  Abstract

In Press

  1. Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe. Lorin Begré, Anders Boyd, Marie-Laure Plissonnier, Barbara Testoni, Charles Béguelin, Franziska Suter-Riniker, Caroline Scholtès, Jürgen K. Rockstroh, Karine Lacombe, Lars Peters, Marintha Heil, Massimo Levrero, Andri Rauch, Fabien Zoulim, Gilles Wandeler for the Swiss HIV Cohort study, EuroSIDA and French HIV/HBV and Biliver cohorts.
    JHEP Reports 2025